Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) — Financial Flexibility Index
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of NT$-4.30 Million (operating CF NT$-20.59 Million minus capex NT$16.29 Million) represents 0% of total liabilities (NT$1.23 Billion). Also explore Chunghwa Chemical Synthesis & Biotech Co annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Chunghwa Chemical Synthesis & Biotech Co Ltd across 18 annual periods. Check strategic asset allocation of Chunghwa Chemical Synthesis & Biotech Co to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Chunghwa Chemical Synthesis & Biotech Co Ltd. For the full company profile including market capitalisation, see Chunghwa Chemical Synthesis & Biotech Co market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | NT$204.94 Million | NT$142.61 Million | NT$1.23 Billion | ▼ -59.1% |
| 2024 | 0.41x | NT$572.35 Million | NT$467.65 Million | NT$1.41 Billion | ▲ +99.1% |
| 2023 | 0.20x | NT$372.49 Million | NT$-77.50 Million | NT$1.82 Billion | ▼ -74.7% |
| 2022 | 0.81x | NT$1.11 Billion | NT$733.78 Million | NT$1.37 Billion | ▲ +92.6% |
| 2021 | 0.42x | NT$624.63 Million | NT$219.18 Million | NT$1.49 Billion | ▼ -17.7% |
| 2020 | 0.51x | NT$331.22 Million | NT$138.24 Million | NT$648.48 Million | ▲ +89.9% |
| 2019 | 0.27x | NT$382.92 Million | NT$268.13 Million | NT$1.42 Billion | ▲ +1.4% |
| 2018 | 0.27x | NT$328.39 Million | NT$234.66 Million | NT$1.24 Billion | ▼ -55.3% |
| 2017 | 0.59x | NT$965.14 Million | NT$159.34 Million | NT$1.63 Billion | ▲ +50.5% |
| 2016 | 0.39x | NT$376.17 Million | NT$261.31 Million | NT$954.48 Million | ▲ +89.9% |
| 2015 | 0.21x | NT$208.98 Million | NT$79.70 Million | NT$1.01 Billion | ▲ +94.7% |
| 2014 | 0.11x | NT$169.67 Million | NT$23.08 Million | NT$1.59 Billion | ▼ -44.5% |
| 2013 | 0.19x | NT$255.28 Million | NT$145.24 Million | NT$1.33 Billion | ▼ -75.0% |
| 2012 | 0.77x | NT$1.03 Billion | NT$268.46 Million | NT$1.34 Billion | ▲ +153.7% |
| 2011 | 0.30x | NT$211.96 Million | NT$144.84 Million | NT$698.59 Million | ▼ -36.2% |
| 2010 | 0.48x | NT$327.11 Million | NT$275.61 Million | NT$687.80 Million | ▲ +6.6% |
| 2009 | 0.45x | NT$498.62 Million | NT$462.07 Million | NT$1.12 Billion | ▲ +446.2% |
| 2008 | 0.08x | NT$117.51 Million | NT$75.39 Million | NT$1.44 Billion | — |